MARKET

NVO

NVO

Novo-Nordisk A/S
NYSE
47.94
-0.40
-0.83%
After Hours: 47.95 +0.01 +0.03% 19:56 06/30 EDT
OPEN
48.51
PREV CLOSE
48.34
HIGH
48.62
LOW
47.87
VOLUME
8.58M
TURNOVER
--
52 WEEK HIGH
68.60
52 WEEK LOW
34.64
MARKET CAP
212.69B
P/E (TTM)
11.32
1D
5D
1M
3M
1Y
5Y
1D
Building A $100,000 Dividend Portfolio With SCHD And July's Top High-Yield Picks
Seeking Alpha · 9h ago
Medicare GLP-1 Bridge Program Will Pay for Novo, Lilly Drugs
Barron‘s · 10h ago
Viking Therapeutics: Updating Pipeline Potential As Oral GLP‑1s Accelerate
Seeking Alpha · 11h ago
BRIEF-Shantha Biologics Entered Into Outsourcing Agreement With Novo Nordisk To Provide Cartridge Fill-Finish Manufacturing Services In India
Reuters · 16h ago
Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday
Benzinga · 17h ago
You Bought HSBC for the Bank. Not the British Pound. Here’s the ETF That Keeps It That Way.
TipRanks · 18h ago
Jefferies Sticks to Their Hold Rating for Novo Nordisk (0QIU)
TipRanks · 1d ago
Canada Approves Apotex's Bid to Sell Generic Version of Wegovy
Dow Jones · 1d ago
More
About NVO
Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Webull offers Novo Nordisk A/S (ADR) stock information, including NYSE: NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NVO stock methods without spending real money on the virtual paper trading platform.